Option chain shows key data for Idorsia's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Idorsia.

Idorsia (OTC:IDRSF) Stock, Option Chain

Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.

Upgrades

Downgrades

Initiation

Intraday Update

Analyst Ratings

ACAD

AGCO

APLE

BRFS

CBOE

COHR

DBVT

FISV

IDRSF

MKTX

NDAQ

NEXA

NTRS

NXGN

OTTR

PINS

PSTI

REGN

REVG

RLMD

SITM

TCNNF

Benzinga&#39;s Top Upgrades, Downgrades For December 16, 2019

News

Markets

Movers

Trading Ideas

AACAY

AAPL

AAVVF

ACLS

AFGC

AIMT

AINV

ALAC

ALLE

ALPMY

AMCI

AMED

ARES

ASMIY

ASML

ASPN

ATKR

ATLKY

BABA

BANF

BNTX

BVSN

BXLC

BXMT

CALB

CBRE

CBSH

CDAY

CDUAF

CIFAF

CKOCF

CMRE

CPWHF

CRUS

CSXXY

DOCU

DSDVY

DTIL

EPZM

EQUEY

Eaton Vance Tax-Advantaged Global Dividend

FBHS

FBNC

FCNCA

FELE

FRPT

FTAI

FTLF

GBERY

GLPG

GMED

GNGBY

GNRC

GOLF

GOOG

GOOGL

HARP

HBAN

Stocks That Hit 52-Week Highs On Friday

ACKRF

ATUS

AVIFY

BEVVF

BURL

CBLK

CDLX

CLKFF

CLTY

CPRX

CRHKY

DANOY

DKMR

DNACF

New Oriental Education & Technology Group

EMLAF

EPRT

GBBT

GLDLF

HEBT

HEI-A

HEMA

HLNE

IMKTA

JBSS

KLAC

KNSL

LAUR

LDOS

LOOP

MAIFF

MEDP

MORN

NSRGF

Nestle Sponsored representing Registered Shares Series B

NSRGY

NXTC

PCTI

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PDRDF

PDRDY

PFSI

RDUS

SBMFF

SHWGY

SSDOY

SSVFF

TCBIP

TERP

TNAV

TORXF

TSGTF

TSPG

WINSTON GOLD MINING ORD by Winston Gold Mining Corp.

WGMCF

XNGSY

XPEL

JMTM

ATBYF

GLGDF

KOOYF

PMMTF

GPPRF

FLMZF

Stocks That Hit 52-Week Highs On Thursday

Idorsia Ltd

JP Morgan analyst Daniel Chen maintains iQIYI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IQ#NASDAQ">IQ</a>) with a Neutral and lowers the price target from $2.5 to $1.8.

Price Target

JP Morgan Maintains Neutral on iQIYI, Lowers Price Target to $1.8

RBC Capital analyst Darko Mihelic reiterates Manulife Financial (TSX:<a class="ticker" href="https://www.benzinga.com/stock/MFC#TSX">MFC</a>) with a Outperform and maintains C$49 price target.

Reiteration

TSX:MFC

RBC Capital Reiterates Outperform on Manulife Financial, Maintains C$49 Price Target

A poll of Benzinga readers found that they don't believe Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) should be broken up. This comes as the Department of Justice (DOJ) suggested divesting the Chrome browser to <a href="https://www.benzinga.com/tech/24/11/42105079/googles-unlawful-behavior-stifles-market-entry-for-rivals-doj-says-alphabet-must-sell-chrome-to-end-search-monopoly">break a search monopoly.</a>
What Happened: Google parent Alphabet has long <a href="https://www.benzinga.com/government/21/07/22094354/could-new-justice-department-hire-lead-to-google-breakup">been a target</a> of potential antitrust investigations due to the company's large market share in online search.
The DOJ recommended that Google share search data with competitors to foster fair competition. The department also said Google should consider selling its Android operating system.
"Google's unlawful behavior has deprived rivals not only of critical distribution channels but also distribution partners who could otherwise enable entry into these markets by competitors in new and innovative ways," the DOJ&nbsp;said in a statement.
A recent poll of Benzinga readers found that they don't believe Alphabet should be split up.
"Should the Department of Justice break up Alphabet (Google)?" Benzinga asked.
The results were:
<ul>
<li>Yes: 36%</li>
<li>No: 64%</li>
</ul>
While the DOJ is targeting Chrome as the potential unit to be divested, Benzinga readers have other preferences.
"Which part of Alphabet would you most want to invest in if it splits up," Benzinga asked.
The results were:
<ul>
<li>YouTube: 43%</li>
<li>Google Search: 31%</li>
<li>Android: 17%</li>
<li>Chrome: 9%</li>
</ul>
Benzinga readers ranked YouTube as the top choice for a standalone unit, while Chrome was the least favored.
Read Also: <a href="https://www.benzinga.com/government/regulations/24/11/42119020/alphabet-bleeds-over-120-billion-in-market-value-eyes-worst-day-in-10-months-after-doj-demands-google-chrome-sale">Alphabet Bleeds Over $120 Billion In Market Value, Eyes Worst Day In 10 Months After DOJ Demands Google Chrome Sale</a>
Why It's Important: While Alphabet likely does not want to split up or sell any of its units, investors could end up the winners <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40378964/google-stock-swings-on-doj-investigation-analyst-says-googl-is-worth-more-in-pieces">according to analysts.</a>
Jefferies analyst Brent Thill recently said that a breakup or business separation could be good for shareholders.
&#8220;We don&#8217;t believe a full breakup would happen. Even if it did, it would be good for shareholders because the sum of the parts is greater than the whole,&#8221; Thill&nbsp;<a href="https://x.com/YahooFinance/status/1823722376716280107" target="_blank" rel="noreferrer noopener">told&nbsp;</a>Yahoo Finance.
Needham analyst Laura Martin has been emphasizing for months that a forced breakup of Alphabet could lead to a significantly higher valuation.
&#8220;We believe that GOOGL is worth more in pieces than together, so we welcome regulators&#8217; attempts to break up GOOGL,&#8221; Martin said in a new investor note.
A break-up could put a spotlight on the valuation of video platform YouTube, Martin said.
&#8220;We calculate that YouTube would be valued between $455B-$643B if separately traded.&#8221;
Martin said Alphabet shares would likely trade higher if the company breaks up because investors would be willing to pay more for &#8220;pure-play assets,&#8221; more data points could be publicly shared, and employees would receive shares in business lines they directly impact.
Martin has a Buy rating on Alphabet and price target of $210.
GOOG Price Action: Alphabet stock trades at $167.81 Friday versus a 52-week trading range of $129.40 to $193.31. Alphabet stock is up 21.3% year-to-date, trailing the 25.6% gain of the SPDR S&amp;P 500 ETF Trust, which tracks the S&amp;P 500.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42131274/why-googles-chrome-battle-isnt-just-about-search-gene-munster-calls-it-a-tough-day-for-big-tech-on-the-regulatory-front">Google&#8217;s Chrome Battle Goes Beyond The Browser: Gene Munster Outlines Wider Implications Of DOJ Going After The Search Giant</a></li>
</ul>
The study was conducted by Benzinga from Nov. 21 through Nov. 22, 2024, and included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 88 adults.
Photo: Shutterstock

Exclusives

Tech

DOJ Targets Google Chrome, Poll Shows 64% Oppose Alphabet Breakup: YouTube Seen As Top Prize

WIIM

SMCI

Super Micro Computer shares are trading higher. The company on Wednesday announced it submitted a compliance plan to Nasdaq.

U.S. stocks traded higher this morning, with the Dow Jones index gaining by more than 300 points on Friday.
Following the market opening Friday, the Dow traded up 0.72% to 44,184.62 while the NASDAQ rose 0.07% to 18,985.33. The S&amp;P 500 also rose, gaining, 0.35% to 5,969.29.
Check This Out: <a href="https://www.benzinga.com/24/11/42135346/top-3-materials-stocks-that-could-blast-off-in-november">Top 3 Materials Stocks That Could Blast Off In November</a>
Leading and Lagging Sectors Consumer staples shares rose by 1% on Friday.
In trading on Friday, communication services shares fell by 0.4%.
Top Headline
Gap, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) reported better-than-expected earnings for its second quarter and raised its outlook for FY24 gross margin.
&nbsp;The company reported quarterly earnings of 54 cents per share, which beat the analyst consensus estimate of 40 cents per share.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>SKK Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKK#NASDAQ">SKK</a>) shares shot up 76% to $1.95 after declining around 75% on Wednesday.</li>
<li>Shares of DevvStream Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DEVS#NASDAQ">DEVS</a>) got a boost, surging 77% to $0.8931.</li>
<li>Replimune Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REPL#NASDAQ">REPL</a>) shares were also up, gaining 48% to $16.37 after the company on Thursday announced it received breakthrough therapy designation status for RP1 and will submit an RP1 biologics license application to the FDA under an accelerated approval pathway.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Autonomix Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) shares dropped 52% to $6.53 after the company announced the pricing of a $9 million underwritten public offering.</li>
<li>Shares of Aptose Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APTO#NASDAQ">APTO</a>) were down 44% to $0.1374 after the company announced the pricing of an $8 million public offering.</li>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) was down, falling 42% to $0.1148 after the company announced its board approved a 1-for-35 reverse stock split.</li>
</ul>
Commodities In commodity news, oil traded up 0.8% to $70.67 while gold traded up 0.9% at $2,697.70.
Silver traded up 1.2% to $31.33 on Thursday, while copper fell 0.8% to $4.0910.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 1.2%, Germany's DAX gained 0.9% and France's CAC 40 rose 0.7%. Spain's IBEX 35 Index rose 0.2%, while London's FTSE 100 gained 1.4%.
The S&amp;P Global UK composite PMI declined to 49.9 in November versus 51.8 in the previous month, while Eurozone composite PMI dipped to 48.1 in November from 50 in the prior month.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 0.68%, Hong Kong's Hang Seng Index falling 1.89%, China's Shanghai Composite Index dipping 3.06% and India's BSE Sensex gaining 2.54%.
Economics
<ul>
<li>The S&amp;P Global US Services PMI climbed to 57 in November versus 55 in the previous month, while manufacturing PMI increased to 48.8 in November from 48.5 in the previous month.</li>
<li>The University of Michigan consumer sentiment for the US fell to 71.8 in November versus a preliminary reading of 73.</li>
<li>The year-ahead inflation expectations in the U.S fell to 2.6% in November from 2.7% in October.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42135946/wall-streets-most-accurate-analysts-give-their-take-on-3-industrials-stocks-with-over-3-dividend-yields-3">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Industrials Stocks With Over 3% Dividend Yields</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Earnings

Equities

Eurozone

AMIX

APTO

CETX

DEVS

REPL

Dow Jumps 300 Points; Gap Posts Upbeat Earnings

RBC Capital analyst Arthur Nagorny reiterates Mattr (TSX:<a class="ticker" href="https://www.benzinga.com/stock/MATR#TSX">MATR</a>) with a Outperform and maintains C$18 price target.

TSX:MATR

RBC Capital Reiterates Outperform on Mattr, Maintains C$18 Price Target

Stock Split

J-Long Group Announces 1-For-10 Reverse Stock Split

JP Morgan analyst Anne Samuel maintains Evolent Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) with a Overweight and lowers the price target from $45 to $15.

JP Morgan Maintains Overweight on Evolent Health, Lowers Price Target to $15

Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) shares are trading higher on Friday. The company has agreed to sell its Personal Protective Equipment (PPE) business to Protective Industrial Products, Inc. (PIP) for <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42135452/honeywell-to-sell-personal-protective-equipment-business-to-protective-industrial-products" rel="noreferrer noopener">$1.325 billion in an all-cash deal</a>.
This move aligns with Honeywell&#8217;s strategy to streamline its portfolio, focusing on core businesses and pursuing high-return acquisitions that support its three key megatrends: automation, the future of aviation, and energy transition.
This sale follows Honeywell&#8217;s 2021 divestiture of its Lifestyle and Performance Footwear Business to Rocky Brands for $230 million, marking the company&#8217;s exit from the PPE sector.
However, Honeywell will retain its gas detection portfolio within the Industrial Automation segment.
The sale of the PPE business is expected to close in the first half of 2025, pending customary conditions.
Vimal Kapur, Chairman and CEO of Honeywell said, &#8221;Now with this transaction, the business will be positioned to accelerate its growth trajectory as it benefits from Odyssey&#8217;s historic investing in the PPE sector and scaling similar businesses&nbsp;to expand into new products, geographies and end markets.&#8221;
&#8220;As we continue to simplify and optimize Honeywell&#8217;s portfolio, the sale of the PPE business will enable us to further strengthen our core business in alignment with our three compelling megatrends.&#8221;
&#8221;The combination of today&#8217;s announcement, with the strategic acquisitions we have made over the past year, positions us to continue to drive profitable growth and strong cash generation while creating compelling long-term value for our shareowners.&#8221;
Last month, Honeywell announced a plan to spin off its Advanced Materials business into an independent, U.S. publicly traded company, which is targeted to be <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41223435/honeywell-announces-plan-to-spin-off-advanced-materials-business-to-shareowners" rel="noreferrer noopener">completed by the end of 2025 or early 2026.</a>
Honeywell held cash and equivalents of about&nbsp;$10.6 billion as of <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41516652/honeywells-mixed-q3-eps-beats-misses-on-sales-and-lowers-fy24-revenue-outlook" rel="noreferrer noopener">September 30, 2024</a>.
Investors can gain exposure to the stock via&nbsp;Amplify CWP Enhanced Dividend Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIVO#NYSE">DIVO</a>) and&nbsp;Invesco Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPA#NYSE">PPA</a>).
Price Action: HON shares are up 1.01% at $228.38 at the last check Friday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42137748" target="_blank" rel="noreferrer noopener">Amid Ongoing Browser Antitrust Scrutiny In US, UK Might Be Next To Challenge Apple And Google&#8217;s Duopoly</a></li>
</ul>

Large Cap

Asset Sales

DIVO

Honeywell Cashes Out: $1.325 Billion PPE Business Sale Fuels Bold Portfolio Transformation

$BTC

Cboe To Launch First Cash-Settled Spot Bitcoin Index Options On December 2, Expanding Investor Access To Crypto Derivatives

JP Morgan analyst Andrew Steinerman maintains Vestis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) with a Neutral and raises the price target from $15 to $16.

JP Morgan Maintains Neutral on Vestis, Raises Price Target to $16

Comments

Idorsia

Idorsia (IDRSF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga